{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "3515903", "DateCompleted": {"Year": "1986", "Month": "04", "Day": "28"}, "DateRevised": {"Year": "2014", "Month": "11", "Day": "20"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0192-415X", "JournalIssue": {"Volume": "14", "Issue": "1-2", "PubDate": {"Year": "1986"}}, "Title": "The American journal of Chinese medicine", "ISOAbbreviation": "Am J Chin Med"}, "ArticleTitle": "B.C.L. and immune response in mice.", "Pagination": {"StartPage": "33", "EndPage": "36", "MedlinePgn": "33-6"}, "Abstract": {"AbstractText": ["The effects of Korean herbal medicine (B.C.L.) on some parameters of immunological response were studied in mice. B.C.L. pretreatment given either intraperitoneally or subcutaneously in a dose of 0.75 mg/mouse did not significantly inhibit lymphocyte transformation induced by concanavalin A. However, B.C.L. pretreatment in a dose of 2.25 mg/mouse was found to reduce significantly both the plaque-forming cells to sheep red blood cells immunisation as well as total spleen cell population. Thus, B.C.L. pretreatment with a higher dose (2.25 mg/mouse) can selectively depress the humoral immune response. It is unclear, however, whether this action is mediated by the parent compound or its metabolites."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Sein", "ForeName": "G M", "Initials": "GM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Am J Chin Med", "NlmUniqueID": "7901431", "ISSNLinking": "0192-415X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Immunosuppressive Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Hemolytic Plaque Technique"}, {"QualifierName": ["drug effects"], "DescriptorName": "Immunity"}, {"QualifierName": [], "DescriptorName": "Immunosuppressive Agents"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lymphocyte Activation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lymphocyte Cooperation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Spleen"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1986", "Month": "1", "Day": "1"}, {"Year": "1986", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1986", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3515903", "10.1142/S0192415X86000065", "S0192415X86000065"]}}]}